Centrum 7/6  banner

“FDA listened and heard” in issuing final rule on OTC hearing aids says CHPA

Print Friendly, PDF & Email

WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement upon the U.S. Food and Drug Administration (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids:

Scott Melville

“Consumer medical devices and other OTC products provide Americans with accessible, affordable, and trusted personal healthcare products, and now FDA has opened the door to a new self-care category: OTC hearing aids. Until now, hearing aids have only been available by prescription, resulting in fewer than one-out-of-five affected people using them. FDA listened and heard CHPA and other stakeholders who provided comments along the way, and we applaud the agency for taking this major step which will have a positive impact on millions of Americans. This FDA final rule would not have been possible but for the leadership of Senators Chuck Grassley, Elizabeth Warren, Marsha Blackburn and former Representative Joe Kennedy who championed the legislation that led to OTC hearing aids,” said Scott Melville, CHPA president and CEO.

 “Thanks to this new rule, consumers will have access to OTC hearing aids as another option to help overcome mild to moderate hearing impairment. CHPA and its members share FDA’s commitment to consumer access, safety, and innovation and we all look forward to seeing OTC hearing aids on the market as soon as this fall,” added John R. Luna, chair of CHPA’s Consumer Medical Devices Committee and CEO of Nuheara

CHPA and stakeholders had requested clarity on the differentiation and scope of customizable hearing aids and self-fitting hearing aids, and had requested package labels to be streamlined, both of which the rule seems to provide for.


Comments are closed.